VICTOR L. CRAWFORD
CIK 1449780 · CEO, Pharmaceutical Segment · last filed 2025-04-03
VICTOR L. CRAWFORD is a CEO, Pharmaceutical Segment who has filed 44 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing, for HSY, was dated Apr 3, 2025. Across all open-market trades the lifetime net is −$687.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $24.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$24.72M
4
44
-$687.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HSY | Director | 4,885 | $181.66 | $887.5K | $0 | 22 | 2025-04-03 |
| CAH | CEO, Pharmaceutical Segment | 105,699 | $223.85 | $23.66M | $0 | 10 | 2022-08-17 |
| PLAY | Director | 13,409 | $12.93 | $173.4K | $0 | 5 | 2020-04-28 |
| PEPSI BOTTLING GROUP INC (PBG) Delisted | SVP, Glbl Ops&Sys Transformatn | 0 | — | — | -$687.9K | 7 | 2010-02-26 |
Recent Filings
44 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-04-03 | HSY | Grant (A) | +99 | $0 | EDGAR |
| 2025-03-18 | HSY | Grant (A) | +113 | $0 | EDGAR |
| 2025-01-03 | HSY | Grant (A) | +251 | $0 | EDGAR |
| 2024-10-02 | HSY | Grant (A) | +221 | $0 | EDGAR |
| 2024-07-02 | HSY | Grant (A) | +231 | $0 | EDGAR |
| 2024-04-03 | HSY | Grant (A) | +220 | $0 | EDGAR |
| 2024-01-26 | HSY | Grant (A) | +229 | $0 | EDGAR |
| 2024-01-03 | HSY | Grant (A) | +270 | $0 | EDGAR |
| 2023-10-03 | HSY | Grant (A) | +210 | $0 | EDGAR |
| 2023-07-05 | HSY | Grant (A) | +170 | $0 | EDGAR |